Cagrilintide

37 aa Amino Acids · MW: N/A

Ask AI About This

Amino Acids

37 aa

Molecular Weight

N/A

Half-life

Several days

Research Score

4.5

Studies

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Cagrilintide?

Cagrilintide is a long-acting amylin analog designed for obesity treatment. It lowers hunger, increases fullness, and supports substantial weight reduction in clinical trials.

Key Benefits & Mechanisms

increased satiety

reduced hunger

lower body weight

slower gastric emptying

Research Summary

Cagrilintide has demonstrated clinically meaningful weight loss as monotherapy and in combination regimens in obesity studies. It is a leading next-generation amylin-pathway agent for appetite control.

Related Peptides

Oxyntomodulin

Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide

Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.

Weight Management

Cotadutide

MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist

Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.

Weight Management

Mazdutide

IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist

Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.

Weight Management

Dulaglutide

Recombinant GLP-1 receptor agonist Fc fusion protein

Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.

Weight Management